203 related articles for article (PubMed ID: 12866298)
1. [Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient].
Sayer HG; Höffken K
MMW Fortschr Med; 2003 Jun; 145(24):40-2. PubMed ID: 12866298
[TBL] [Abstract][Full Text] [Related]
2. [Antiestrogen therapy in the treatment of breast neoplasms].
Alba E; Ragonesi G; Colla F; Mazzoleni A; Farina C
Minerva Ginecol; 2002 Jun; 54(3):245-51. PubMed ID: 12063440
[TBL] [Abstract][Full Text] [Related]
3. [Antiestrogen treatment in postmenopausal patients with metastatic breast cancer].
Lindberg H; Nielsen DL; Tuxen M; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3096-100. PubMed ID: 17877958
[TBL] [Abstract][Full Text] [Related]
4. The prevention, detection, and management of breast cancer.
Houssami N; Cuzick J; Dixon JM
Med J Aust; 2006 Mar; 184(5):230-4. PubMed ID: 16515434
[TBL] [Abstract][Full Text] [Related]
5. Upstaging tamoxifen? New classes of drugs emerging for breast cancer.
Twombly R
J Natl Cancer Inst; 2002 Apr; 94(7):474-5. PubMed ID: 11929942
[No Abstract] [Full Text] [Related]
6. [The role of aromatase inhibitors in the treatment of breast neoplasms. An evaluation of clinical efficacy and the tolerability profile].
Porpiglia M; Genta F; Vicelli R; De Nicola B; Ferraris F; Piccinno R; Benedetto C
Minerva Ginecol; 2002 Apr; 54(2):115-31. PubMed ID: 12032450
[TBL] [Abstract][Full Text] [Related]
7. Toremifene and letrozole for advanced breast cancer.
Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744
[No Abstract] [Full Text] [Related]
8. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
Wu K; Brown P
J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921
[No Abstract] [Full Text] [Related]
9. Hormones 'R' us.
Sledge GW
Clin Breast Cancer; 2002 Jan; 2(4):251. PubMed ID: 11899355
[No Abstract] [Full Text] [Related]
10. [The ATAC study on adjuvants in breast cancer].
Bravi S
Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
[No Abstract] [Full Text] [Related]
11. Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.
Munster PN; Horton J
Cancer Control; 2001; 8(6):478-9. PubMed ID: 11807416
[No Abstract] [Full Text] [Related]
12. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
Howell A; Cuzick J; Baum M; Buzdar A; Dowsett M; Forbes JF; Hoctin-Boes G; Houghton J; Locker GY; Tobias JS;
Lancet; 2005 Jan 1-7; 365(9453):60-2. PubMed ID: 15639680
[TBL] [Abstract][Full Text] [Related]
13. Effects of high dose raloxifene in selected patients with advanced breast carcinoma.
Gradishar W; Glusman J; Lu Y; Vogel C; Cohen FJ; Sledge GW
Cancer; 2000 May; 88(9):2047-53. PubMed ID: 10813716
[TBL] [Abstract][Full Text] [Related]
14. [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
Gamucci T
Suppl Tumori; 2004; 3(4):S16. PubMed ID: 15206201
[No Abstract] [Full Text] [Related]
15. Overview of randomized trials of systemic adjuvant therapy.
Ravdin PM
Cancer Treat Res; 2000; 103():157-81. PubMed ID: 10948446
[No Abstract] [Full Text] [Related]
16. New options in the prevention and treatment of breast carcinoma.
Galleshaw J
J Med Assoc Ga; 2003; 92(1):19-22. PubMed ID: 12743901
[No Abstract] [Full Text] [Related]
17. [Advances in the treatment of breast carcinoma. New therapy schedules with astonishing success quotas].
Aumiller J
MMW Fortschr Med; 2006 Mar; 148(12):4-6, 8. PubMed ID: 16625995
[No Abstract] [Full Text] [Related]
18. Breast cancer. Clinical practice guidelines in oncology.
Carlson RW; Allred DC; Anderson BO; Burstein HJ; Carter WB; Edge SB; Erban JK; Farrar WB; Goldstein LJ; Gradishar WJ; Hayes DF; Hudis CA; Jahanzeb M; Kiel K; Ljung BM; Marcom PK; Mayer IA; McCormick B; Nabell LM; Pierce LJ; Reed EC; Smith ML; Somlo G; Theriault RL; Topham NS; Ward JH; Winer EP; Wolff AC;
J Natl Compr Canc Netw; 2009 Feb; 7(2):122-92. PubMed ID: 19200416
[No Abstract] [Full Text] [Related]
19. Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.
Colleoni M; Munzone E
Drugs; 2015 Aug; 75(12):1311-21. PubMed ID: 26177891
[TBL] [Abstract][Full Text] [Related]
20. Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
Ruddy KJ; DeSantis SD; Barry W; Guo H; Block CC; Borges V; Winer EP; Partridge AH
Clin Breast Cancer; 2014 Dec; 14(6):413-6. PubMed ID: 24970714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
